BeStock  
股票 › ABBV

艾伯维 ABBV

美股市值排名 #28
$291.31 +$3.07 (+1.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $291.31 0.00%
开盘$282.27
昨收$288.24
当日区间$281.07 – $291.73
成交量5.04M
市值$514.92B
市盈率(TTM)50.1
股息率2.34%

基本面

最新报告季度:Q3, ended Sep 2026

营收$17.40B+10.3% YoY
营业利润$6.48B+41.4% YoY
净利润$4.22B+2,144.7% YoY
摊薄每股收益$2.37+2,270.0% YoY
自由现金流$3.11B-36.2% YoY
经营现金流$3.44B

营收,近8个季度

$15.1BDec '24$13.3BMar '25$15.4BJun '25$15.8BSep '25$16.6BDec '25$15.0BMar '26$17.0BJun '26$17.4BSep '26

净利润,近8个季度

$-23.0MDec '24$1.3BMar '25$941.0MJun '25$188.0MSep '25$1.8BDec '25$697.0MMar '26$3.6BJun '26$4.2BSep '26

各季度摊薄每股收益

-0.02Dec '240.72Mar '250.52Jun '250.10Sep '251.02Dec '250.39Mar '262.03Jun '262.37Sep '26

各季度自由现金流

$5.2BSep '24$6.8BDec '24$1.4BMar '25$4.9BJun '25$6.6BSep '25$4.9BDec '25$3.6BMar '26$3.1BJun '26

年度营收

$45.8BFY20$56.2BFY21$58.1BFY22$54.3BFY23$56.3BFY24$61.2BFY25

盈利能力与资产负债表

毛利率73.7%
营业利润率36.0%
净利率15.7%
负债/资产比率104.4%
现金及投资$6.57B
总负债$70.82B
净现金(净负债)-$64.25B

营收构成

2026/Q2 季度

按业务线

  • SKYRIZI$5.51B 32.4%
  • Other$2.95B 17.4%
  • RINVOQ$2.53B 14.9%
  • All other$1.11B 6.5%
  • Vraylar$1.07B 6.3%
  • Botox Therapeutic$1.04B 6.1%
  • VENCLEXTA$771.00M 4.5%
  • HUMIRA$756.00M 4.4%
  • Botox Cosmetic$728.00M 4.3%
  • IMBRUVICA$532.00M 3.1%

利润表

项目 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
报告营业总收入 $17.40B $16.99B $15.00B $61.16B $16.62B
营业总收入 $17.40B $16.99B $15.00B $61.16B $16.62B
营业成本 $4.29B $4.29B $4.22B $18.20B $4.55B
毛利润 $13.12B $12.70B $10.78B $42.96B $12.07B
营业费用 $6.64B $5.98B $6.05B $22.87B $6.26B
销售及管理费用 $4.09B $3.63B $3.58B $14.01B $3.90B
研发费用 $2.57B $2.34B $2.47B $9.10B $2.58B
其他营业费用 -$18.00M – – -$241.00M -$217.00M
营业利润 $6.48B $6.72B $4.73B $20.09B $5.81B
非经营性利息净收入(支出) -$700.00M -$679.00M -$645.00M -$2.63B -$655.00M
非经营性利息支出 $700.00M $746.00M $717.00M $2.89B $714.00M
其他收入(支出) -$954.00M -$1.77B -$3.05B -$10.87B -$2.49B
特殊收益(费用) -$216.00M -$291.00M -$744.00M -$5.02B -$1.27B
-减:其他特殊支出 $216.00M $291.00M $744.00M $5.02B $1.27B
其他非经营性收入(支出) -$738.00M -$1.48B -$2.31B -$5.79B -$1.21B
税前利润 $4.83B $4.28B $1.04B $6.60B $2.67B
税费 $609.00M $662.00M $342.00M $2.36B $853.00M
净利润 $4.22B $3.62B $697.00M $4.23B $1.82B
持续经营利润 $4.22B $3.62B $697.00M $4.23B $1.82B
少数股东权益 $2.00M $3.00M $2.00M $7.00M -$1.00M
归属母公司净利润 $4.22B $3.61B $695.00M $4.23B $1.82B
归属普通股股东净利润 $4.22B $3.60B $685.00M $4.19B $1.81B
基本每股收益 $2.39 $2.04 $0.39 $2.37 $1.03
摊薄每股收益 $2.37 $2.03 $0.39 $2.37 $1.02
每股股息 $1.73 $1.73 $1.73 $6.56 $1.64
非经营性利息收入 – $67.00M $72.00M $266.00M $59.00M
其他优先股股息 – $12.00M $10.00M $40.00M $10.00M
证券出售收益 – – – -$58.00M -$11.00M

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $135.12B $136.46B $133.96B $133.96B $133.90B
流动资产合计 $33.67B $33.53B $29.06B $29.06B $28.54B
现金及现金等价物与短期投资 $6.57B $9.39B $5.26B $5.26B $5.67B
-现金及现金等价物 $6.57B $9.39B $5.23B $5.23B $5.63B
应收款 $13.82B $12.48B $12.59B $12.59B $12.77B
-应收账款 $13.82B $12.48B $12.59B $12.59B $12.77B
存货 $5.13B $5.05B $4.95B $4.95B $4.94B
其他流动资产 $8.15B $6.61B $6.27B $6.27B $5.16B
非流动资产合计 $101.45B $102.93B $104.90B $104.90B $105.36B
固定资产净值 $5.80B $5.69B $5.63B $5.63B $5.48B
-固定资产原值 $13.96B $13.73B $13.53B $13.53B $13.23B
-累计折旧 -$8.16B -$8.04B -$7.90B -$7.90B -$7.75B
投资及预付款 $266.00M $268.00M $268.00M $268.00M $291.00M
商誉及其他无形资产 $84.66B $86.44B $88.28B $88.28B $89.94B
-商誉 $35.52B $35.57B $35.64B $35.64B $35.63B
-其他无形资产 $49.14B $50.87B $52.64B $52.64B $54.32B
其他非流动资产 $10.73B $10.54B $10.72B $10.72B $9.64B
负债合计 $141.00B $143.08B $137.19B $137.19B $136.50B
流动负债合计 $41.64B $42.10B $43.29B $43.29B $39.39B
短期债务及融资租赁负债 $8.34B $8.33B $8.56B $8.56B $5.77B
-一年内到期债务 $8.34B $8.33B $8.56B $8.56B $5.77B
非流动负债合计 $99.36B $100.98B $93.90B $93.90B $97.11B
长期债务及融资租赁负债 $62.48B $64.53B $58.94B $58.94B $62.97B
-长期债务 $62.48B $64.53B $58.94B $58.94B $62.97B
一年以上递延负债 $2.28B $2.33B $2.39B $2.39B $2.48B
其他非流动负债 $34.60B $34.11B $30.80B $30.80B $31.66B
股东权益合计 -$5.89B -$6.61B -$3.23B -$3.23B -$2.60B
股东权益 -$5.94B -$6.66B -$3.27B -$3.27B -$2.64B
股本 $18.00M $18.00M $18.00M $18.00M $18.00M
-普通股 $18.00M $18.00M $18.00M $18.00M $18.00M
资本公积 $23.16B $22.96B $22.50B $22.50B $22.29B
留存收益 -$17.33B -$17.87B -$15.49B -$15.49B -$14.23B
减:库存股 $10.62B $10.61B $9.15B $9.15B $9.14B
不影响留存收益的损益 -$1.16B -$1.15B -$1.14B -$1.14B -$1.57B
少数股东权益 $47.00M $44.00M $42.00M $42.00M $43.00M
-短期投资 – – $28.00M $28.00M $42.00M
应付款 – – $6.69B $6.69B –
-应付账款 – – $3.59B $3.59B –
-应付股利 – – $3.10B $3.10B –
一年内应计费用 – – $28.04B $28.04B –
长期应付账款及其他应付款 – – $364.00M $364.00M –
员工福利 – – $1.41B $1.41B –

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $3.44B $3.83B $19.03B $5.22B $7.02B
持续经营经营活动现金流净额 $3.44B $3.83B $19.03B $5.22B $7.02B
持续经营净利润 $3.62B $697.00M $4.23B $1.82B $188.00M
折旧、折耗与摊销 $1.88B $1.94B $8.14B $1.99B $2.06B
递延税款 -$195.00M $137.00M -$492.00M -$385.00M $193.00M
其他非现金项目 $601.00M $2.54B $8.64B $1.98B $2.59B
营运资金变动 -$2.72B -$1.92B -$2.36B -$473.00M $1.25B
-应收款变动 -$1.37B $87.00M -$1.49B $162.00M -$156.00M
-存货变动 -$143.00M -$184.00M -$234.00M -$25.00M $2.00M
-预付资产变动 -$188.00M -$150.00M -$827.00M -$658.00M $88.00M
-应付账款及应计费用变动 $1.20B -$1.59B $951.00M -$598.00M $1.73B
-其他营运资金变动 -$2.22B -$81.00M -$762.00M $646.00M -$411.00M
投资活动现金流净额 -$1.20B -$574.00M -$6.64B -$1.46B -$3.26B
持续经营投资活动现金流净额 -$1.20B -$574.00M -$6.64B -$1.46B -$3.26B
固定资产购置及出售净额 -$322.00M -$265.00M -$1.21B -$329.00M -$381.00M
业务购买及出售净额 -$824.00M -$266.00M -$5.44B -$1.16B -$2.80B
其他投资变动净额 -$51.00M -$43.00M -$29.00M -$1.00M -$94.00M
筹资活动现金流 -$5.05B $919.00M -$12.72B -$4.17B -$4.59B
持续经营筹资活动现金流净额 -$5.05B $919.00M -$12.72B -$4.17B -$4.59B
债务发行及偿还净额 -$2.00B $5.49B -$304.00M -$1.30B -$1.78B
普通股发行净额 -$9.00M -$1.49B -$980.00M -$3.00M -$4.00M
已付现金股利 -$3.07B -$3.09B -$11.66B -$2.91B -$2.91B
其他筹资费用净额 $25.00M $2.00M $45.00M -$1.00M -$24.00M
期末现金余额 $6.57B $9.39B $5.23B $5.23B $5.63B
现金净变动 -$2.82B $4.17B -$337.00M -$411.00M -$830.00M
期初现金余额 $9.39B $5.23B $5.52B $5.63B $6.47B
汇率变动影响 -$7.00M -$12.00M $42.00M $11.00M -$8.00M
自由现金流 $3.11B $3.56B $17.82B $4.89B $6.64B
投资购置及出售净额 – – $41.00M $28.00M -$4.00M
股票期权行使所得 – – $172.00M $48.00M $63.00M

讨论区

暂无评论——快来第一个聊聊 ABBV。

登录后参与讨论。

Scroll to Top